Extramedullary sudden blast crisis in chronic-phase chronic myeloid leukemia during first-line treatment with nilotinib.
Resource Type
Report
Authors
Angelopoulou MK; Department of Hematology and BMT Unit, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece.; Asimakopoulos JV; Department of Hematology and BMT Unit, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece.; Galani Z; Department of Hematology and BMT Unit, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece.; Levidou G; 1st Department of Pathology, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece.; Roumelioti M; Molecular Hematology Laboratory, 1st Department of Propaedeutic Medicine, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece.; Vassilakopoulos TP; Department of Hematology and BMT Unit, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece.; Korkolopoulou P; 1st Department of Pathology, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece.; Panayiotidis P; Molecular Hematology Laboratory, 1st Department of Propaedeutic Medicine, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece.
Source
Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE